Neural Modulation System with Integrated AI, IoT, and Blockchain Technologies

The present inventive concept integrates an implantable electrical modulator with advanced technologies such as AI, IoT, and blockchain to create a more effective and secure system for neural modulation, enhancing the treatment of various physiological conditions and disorders.

The original patent disclosed an implantable electrical modulator for neural modulation. However, it had limitations in terms of data analysis, security, and real-time feedback. The present inventive concept addresses these limitations by incorporating AI, IoT, and blockchain technologies to provide a more comprehensive and effective system for neural modulation.

The neural modulation system comprises an implantable electrical modulator, a neural network module for processing and analyzing neural signals, a wearable IoT device for tracking and transmitting neural signals, a machine learning module for adjusting the modulation of the nerve, a blockchain-based data storage system for secure storage and analysis of neural signals, and a computer vision module for tracking the movement of the subject's tongue. The system integrates these components to provide real-time feedback, optimize the modulation of the nerve, and securely store and analyze neural signals.

The integration of AI, IoT, and blockchain technologies with the implantable electrical modulator provides a new and non-obvious solution for neural modulation, overcoming the limitations of the original patent and providing a more effective and secure system.

Alternative embodiments of the inventive concept may include the use of different AI algorithms, IoT devices, or blockchain platforms. Variations may include the integration of additional sensors or devices to provide more comprehensive data analysis and feedback.

The neural modulation system with integrated AI, IoT, and blockchain technologies has significant commercial potential in the treatment of various physiological conditions and disorders, including sleep breathing disorders, epilepsy, and chronic pain. The target industries include healthcare, medical devices, and pharmaceuticals.